Colistin and rhabdomyolysis: A causative agent or an innocent bystander? [9]

Intensive Care Medicine

Volumn 33, Issue 3, 2007, Pages 556-557

  Evagelopoulou, Penelope ^a,b   Katsaros, Andreas ^a   Myrianthefs, Pavlos ^a   Karatzas, Stylianos ^a   Boutzouka, Eleni ^a   Fildissis, George ^a   Baltopoulos, George ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATRACURIUM; COLISTIN; CORTISONE; CREATINE KINASE; GENTAMICIN; MEROPENEM; NEOMYCIN; RIFAMPICIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC REACTION; BACTEREMIA; CASE REPORT; CONTINUOUS HEMODIAFILTRATION; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LETTER; RHABDOMYOLYSIS; SHOCK; VENTILATOR ASSOCIATED PNEUMONIA; WHOLE BODY CT;

ADULT; ANTI-BACTERIAL AGENTS; COLISTIN; CREATINE KINASE; FEMALE; HUMANS; RHABDOMYOLYSIS;

EID: 33847362741     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0515-9     Document Type: Letter

References (7)

1. Huerta-Alardin AL, Varon J, Marik P (2005) Bench to bedside review: Rhabdomyolysis?an overview for clinicians. Critical Care 9:158-169
2. Holt S, Moore K (2001) Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med 27:803-811
3. Hameed S, Aird W, Cohn S (2003) Oxygen delivery. Crit Care Med (Suppl) 31:12
4. Falagas ME, Kasiakou SK (2006) Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Critical Care 10:R27
5. Hermsen ED, Sullivan CJ, Rotschafer JC (2003) Polymyxins: pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications. Infect Dis Clin North Am 17:545-562
6. Lewis JR, Lewis SA (2004) Colistin interactions with mammalian urothelium. Am J Physiol Cell Physiol 286:C913-C922
7. Berg JR, Spilker CM, Lewis SA (1998) Modulation of polymyxin B effects on mammalian urinary bladder. Am J Physiol 275:F204-F215